Patents by Inventor Hans-Ludwig Schafer

Hans-Ludwig Schafer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030158119
    Abstract: The present invention is directed to a 1,4-benzothiepine 1,1-dioxide compound of formula I 1
    Type: Application
    Filed: August 22, 2002
    Publication date: August 21, 2003
    Inventors: Heiner Glombik, Wendelin Frick, Hans-Ludwig Schafer, Werner Kramer
  • Publication number: 20030158094
    Abstract: The present invention is directed to an aryl-substituted propanolamine derivative of formula I 1
    Type: Application
    Filed: August 22, 2002
    Publication date: August 21, 2003
    Inventors: Heiner Glombik, Wendelin Frick, Hans-Ludwig Schafer, Werner Kramer
  • Publication number: 20030144332
    Abstract: Diarylcycloalkyl derivatives and their physiologically acceptable salts and physiologically functional derivatives are disclosed.
    Type: Application
    Filed: August 30, 2002
    Publication date: July 31, 2003
    Inventors: Heiner Glombik, Eugen Falk, Wendelin Frick, Stefanie Keil, Hans-Ludwig Schafer, Lothar Schwink, Wolfgang Wendler
  • Patent number: 6569835
    Abstract: Substituted propanolamine derivatives, their pharmaceutically tolerated salts and physiologically functional derivatives thereof are described. Also described are compounds of formula I in which the radicals have the abovementioned meanings, and their physiologically tolerated salts, physiologically functional derivates and processes for their preparation. The compounds are suitable as, for example, hypolipidemics.
    Type: Grant
    Filed: November 1, 2001
    Date of Patent: May 27, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Wendelin Frick, Reinhard Kirsch, Heiner Glombik, Werner Kramer, Hans-Ludwig Schäfer
  • Patent number: 6566340
    Abstract: Substituted propanolamine derivatives, their pharmaceutically tolerated salts and physiologically functional derivatives thereof are described. Also described are compounds of formula I in which the radicals have the abovementioned meanings, and their physiologically tolerated salts, physiologically functional derivates and processes for their preparation. The compounds are suitable as, for example, hypolipidemics.
    Type: Grant
    Filed: April 13, 2001
    Date of Patent: May 20, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Wendelin Frick, Reinhard Kirsch, Heiner Glombik, Werner Kramer, Hans-Ludwig Schäfer
  • Publication number: 20020177610
    Abstract: Substituted propanolamine derivatives, their pharmaceutically tolerated salts and physiologically functional derivatives thereof are described.
    Type: Application
    Filed: November 1, 2001
    Publication date: November 28, 2002
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Wendelin Frick, Reinhard Kirsch, Heiner Glombik, Werner Kramer, Hans-Ludwig Schafer
  • Publication number: 20020137689
    Abstract: Compounds of the formula I, 1
    Type: Application
    Filed: December 19, 2001
    Publication date: September 26, 2002
    Inventors: Heiner Glombik, Werner Krame, Stefanie Flohr, Wendelin Frick, Hubert Heuer, Gerhard Jaehne, Andreas Lindenschmidt, Hans-Ludwig Schafer
  • Patent number: 6451781
    Abstract: Substituted acylguanidines and their pharmaceutically tolerable salts and physiologically functional derivatives. Compounds of the formula I in which the radicals have the meanings indicated, and their physiologically tolerable salts, physiologically functional derivatives and a process for their preparation are described. The compounds are suitable, for example, as medicaments for the prophylaxis or treatment of gallstones.
    Type: Grant
    Filed: September 5, 2000
    Date of Patent: September 17, 2002
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Heinz-Werner Kleemann, Armin Hofmeister, Eugen Falk, Hans-Willi Jansen, Hans-Ludwig Schäfer
  • Publication number: 20020128252
    Abstract: Compounds of the formula I, 1
    Type: Application
    Filed: December 19, 2001
    Publication date: September 12, 2002
    Inventors: Heiner Glombik, Werner Kramer, Stefanie Flohr, Wendelin Frick, Hubert Heuer, Gerhard Jaehne, Andreas Lindenschmidt, Hans-Ludwig Schafer
  • Publication number: 20020042381
    Abstract: Substituted propanolamine derivatives, their pharmaceutically tolerated salts and physiologically functional derivatives thereof are described.
    Type: Application
    Filed: April 13, 2001
    Publication date: April 11, 2002
    Applicant: Hoechst Marion Roussel Deutschland GmbH
    Inventors: Wendelin Frick, Reinhard Kirsch, Heiner Glombik, Werner Krammer, Hans-Ludwig Schafer
  • Patent number: 6277831
    Abstract: The invention relates to substituted 1,4-benzothiazepine-1,1-dioxide derivatives and their acid addition salts. 1,4-Benzothiazepine-1,1-dioxide derivatives of formula 1, wherein R1, R2, R3, and Z have the meanings indicated in the specification, physiologically tolerable salts, and physiologically functional derivatives thereof, and also processes for their preparation, are described. The compounds are suitable, for example, as hypolipidemics.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: August 21, 2001
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Wendelin Frick, Heiner Glombik, Hubert Heuer, Hans-Ludwig Schäfer
  • Patent number: 6245744
    Abstract: Substituted propanolamine derivatives, their pharmaceutically tolerated salts and physiologically functional derivatives thereof are described. Also described are compounds of formula I in which the radicals have the abovementioned meanings, and their physiologically tolerated salts, physiologically functional derivates and processes for their preparation. The compounds are suitable as, for example, hypolipidemics.
    Type: Grant
    Filed: October 1, 1999
    Date of Patent: June 12, 2001
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Wendelin Frick, Reinhard Kirsch, Heiner Glombik, Werner Kramer, Hans-Ludwig Schäfer
  • Patent number: 5939424
    Abstract: The invention relates to 4-Amino-2-ureidopyrimidine-5-carboxamides of the formula I ##STR1## in which R.sup.1 is H or (C.sub.1 -C.sub.8)-alkyl, where one or more H can be replaced by F; R.sup.2 is selected from the group consisting of F, Cl, Br, H, -O-(C.sub.1 -C.sub.8)-alkyl, and -S-(C.sub.1 -C.sub.8)-alkyl, where the alkyl groups have one or more H replaced by F; R.sup.3 is -O-(C.sub.1 -C.sub.8)-alkyl or -S-(C.sub.1 -C.sub.8)-alkyl, where the alkyl groups have one or more H replaced by F; or R.sup.2 and R.sup.3 together form -O-(C.sub.1 -C.sub.5)-alkylene-O-, where the alkylene portion has one or more H replaced by F; and their physiologically tolerable salts. The invention further provides processes for preparing the compounds of formula I. The compounds are suitable for the treatment of disorders of lipid metabolism.
    Type: Grant
    Filed: June 4, 1997
    Date of Patent: August 17, 1999
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Hans Georg Boger, Axel Hoffmann, Gerhard Jahne, Norbert Krass, Hans-Ludwig Schafer
  • Patent number: 5434141
    Abstract: The use of galacturonic acid and derivatives thereof for preparing a medicament for the treatment of hyperlipidaemia and/or atherosclerosis is described.
    Type: Grant
    Filed: December 6, 1991
    Date of Patent: July 18, 1995
    Assignee: Steigerwald Arzneimittelwerk GmbH
    Inventors: Hans-Ludwig Schafer, Werner Schneider